Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease - Wikidata - awgldk - TriplyDB

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

http://www.wikidata.org/entity/Q36604677

about

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics Two endoplasmic reticulum (ER)/ER Golgi intermediate compartment-based lysine acetyltransferases post-translationally regulate BACE1 levels Regulation of cellular response to oncogenic and oxidative stress by Seladin-1 The complex life of simple sphingolipids Pathways towards and away from Alzheimer's disease Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease Mammalian ceramide synthases Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) attenuates the expression of LPS- and Abeta peptide-induced inflammatory mediators in astroglia.The Role of Oxidative Stress in Etiopathogenesis of Chemotherapy Induced Cognitive Impairment (CICI)-"Chemobrain"Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases Recent advances in the application of metabolomics to Alzheimer's Disease Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticity Cholesterol balance in prion diseases and Alzheimer's disease Mitochondrial dysfunction: different routes to Alzheimer's disease therapy Fingolimod for the treatment of neurological diseases-state of play and future perspectives A fluorescent glycolipid-binding peptide probe traces cholesterol dependent microdomain-derived trafficking pathways Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation Arf6 controls retromer traffic and intracellular cholesterol distribution via a phosphoinositide-based mechanism.Ceramides in Alzheimer's Disease: Key Mediators of Neuronal Apoptosis Induced by Oxidative Stress and Aβ Accumulation Autophagy regulates sphingolipid levels in the liver Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry Mitochondrial lipids in neurodegeneration A neurotoxic glycerophosphocholine impacts PtdIns-4, 5-bisphosphate and TORC2 signaling by altering ceramide biosynthesis in yeast Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties Interleukin-1 beta impairs brain derived neurotrophic factor-induced signal transduction Regulation of neutral sphingomyelinase-2 by GSH: a new insight to the role of oxidative stress in aging-associated inflammation Naturally occurring genetic variability in expression of Gsta4 is associated with differential survival of axotomized rat motoneurons Effects of NK-4 in a transgenic mouse model of Alzheimer's disease Gene expression changes in female zebrafish (Danio rerio) brain in response to acute exposure to methylmercury Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration.Ceramide-mediated insulin resistance and impairment of cognitive-motor functions Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors.Glycolipid trafficking in Drosophila undergoes pathway switching in response to aberrant cholesterol levels

P2860

Q21560953-6AF37124-816D-42CE-A00F-2C4331124152 Q24314953-9D3F6A2A-1328-413C-BD63-DA6564CCF154 Q24319120-B864D770-6065-46B1-8C26-0F6A92776FAF Q24537161-B81DFD79-CAEB-44F1-8C78-04A63689D135 Q24596270-90C30C1A-DB92-48E1-AEA9-626C753BC511 Q24620476-DDB7FE16-F65A-4D73-833D-46D95E9F30B5 Q24627125-7A728714-28D4-4452-85F5-200E58F19387 Q24633453-F2800D0F-79F3-49AF-AAB0-4B4F9FBEFF52 Q24682639-991390CB-D629-4BC6-8377-228AA4472D9A Q24815455-5C9BA816-7821-43C2-BEDE-103A8D1324D1 Q26743578-73EAE8E8-40B8-4E42-87D9-C981268FE917 Q26765300-5DF788FC-6EA5-49D1-A96E-F2B01573B161 Q26785969-5B10CB36-59E5-4CAD-8275-AFEE74D0768C Q26828606-48B11B84-D255-4C45-8604-DDAE5DCF9F9B Q26853611-81D22369-9ABA-4292-8F62-602EC82C1117 Q27002948-366F5B85-A0FD-476F-A274-1E6F8CB96FB6 Q27009475-3AB80A5B-1941-46D8-9A78-72BBA2B4EF83 Q27026175-B411F4BA-E23F-4D8E-A423-B97B7C9C8BCA Q27300755-3622DB18-AF41-4A18-822A-935454E12E84 Q27310161-F3D2CECA-A77F-471C-80DE-EBE402D5C4EF Q27340503-0B6E52EF-DC25-4AE2-8068-0D151ED2B977 Q27343089-798ADEBF-2389-4B5E-BAE6-25A333171EDA Q28087030-EAF4D66F-586A-4108-9C88-E92F8894800A Q28115515-A245A296-3537-4778-A7AD-F4FDEA81701B Q28270227-AAFA2D27-E585-456F-AE06-B26A327AA674 Q28384232-35FB79FC-1C9A-47C0-A48B-E00BAF113605 Q28386524-02867DAF-8A56-4B42-AA7C-AB1A42D66A04 Q28391606-A494AB28-7E4B-4E12-BC90-4AF648D9BBFA Q28397548-36A618EC-5E41-4E10-9CA2-F5051954E148 Q28539054-74CA1300-434A-4B94-A4B5-89A8A121F006 Q28547451-4483F229-8B31-4D42-83B5-4C3BE00C00CE Q28576073-B09878D9-927C-4989-B81B-753D48A6DB44 Q28579066-54D9231B-8A97-4720-B02E-D27ADE27294E Q28580736-14DCEC5E-85CE-4709-9500-1BE77BA5EF52 Q28740342-EC8CC1B3-DBB8-42A5-AED8-89FC1C85A527 Q30396325-6E707EF7-448D-401A-8406-82F3E11FDABB Q30427825-C068E029-A16B-4194-A73C-8E541A4FB45A Q30478907-01E69FF4-5B7F-48E1-947F-8B13BD16ACF1 Q30487868-66D63ABF-7E16-4AE7-9243-04373EAACF10 Q30493377-F1406E72-C8EB-4B8C-9003-4BC454533666

P2860

Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease

http://www.wikidata.org/entity/Q36604677

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Involvement of oxidative stres ...... aging and Alzheimer's disease

@ast

Involvement of oxidative stres ...... aging and Alzheimer's disease

@en

type

label

Involvement of oxidative stres ...... aging and Alzheimer's disease

@ast

Involvement of oxidative stres ...... aging and Alzheimer's disease

@en

prefLabel

Involvement of oxidative stres ...... aging and Alzheimer's disease

@ast

Involvement of oxidative stres ...... aging and Alzheimer's disease

@en

P1433

Q36604677-D3865A68-B591-4FB1-9EB0-CD1D48141E4A

P1476

Q36604677-045F458D-70CF-45A5-9436-97C73D9955E3

P2093

Q36604677-091774E6-8CDE-4B70-B566-1C3F546A4A8A

Q36604677-636E707E-B5D1-40E6-AAD5-1FA0F8E3EFCA

Q36604677-7DDF3592-86BE-4096-990E-D3BF37BFA270

Q36604677-B653AB93-25C6-45D7-BCE1-AB707FA59D3F

Q36604677-CFE4B8AB-6A8D-4DCD-83DC-3497F8841A6B

Q36604677-E8568819-DFE4-40F6-BA77-AE6D31EAD66B

Q36604677-F3585089-883C-4AD0-9D5C-BABFA2787BE7

P2860

Q36604677-00A1DCDC-66DA-47C2-9FF2-842DFF4F6F50

Q36604677-152A1F14-74E3-402E-93DA-6BE93DDD5E3B

Q36604677-169E17E2-D170-4935-9516-A26C0711010A

Q36604677-16B1DD3F-2F7C-4572-A3B2-440CAFAC0892

Q36604677-17F96EE7-C5AB-4C45-A951-44B1FE821919

Q36604677-1C1B4BC8-2A55-47C9-AA78-0CE827A08448

Q36604677-1E8F38F8-AC6C-415D-A735-1AE75E6BFB87

Q36604677-26E023E5-5B61-452C-8BDA-BB01128C824B

Q36604677-313EF2DE-5171-4EE7-8546-6F76832F628D

Q36604677-31C55153-FE06-463F-AB8C-BDCD01E8D3EC

P304

Q36604677-B8F90F65-038C-4502-A18A-5FEC805BCA51

P31

Q36604677-EC52EB71-3E76-4109-B21D-398002C8FE11

P356

Q36604677-D1CCC74C-D7F8-4EC2-A050-BC791BDFE9CE

P407

Q36604677-BBD79E72-979C-42D0-88C0-E3B8A3067075

P433

Q36604677-F52C4B29-C93F-46FC-818B-4BB312B40BDF

P478

Q36604677-816B8721-9A55-4931-850C-E1181BE07586

P50

Q36604677-A06EA8F8-AECB-49CD-9A40-AB41919D1CE8

P577

Q36604677-A6463D83-A034-4FE3-B2DD-322D33E83E96

P5875

Q36604677-369D7C3E-3EC4-423B-9837-EA8479D23594

P698

Q36604677-FECDA244-EB8D-4C1B-8D76-C548790E4B52

P921

Q36604677-D55AD058-916D-45DB-AC6F-C3630C000497

P932

Q36604677-0BF92AB1-5A46-4B80-B647-B9981C40A80E

P356

PNAS.0305799101

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Involvement of oxidative stres ...... aging and Alzheimer's disease

@en

P2093

Anita Tammara

http://www.w3.org/2001/XMLSchema#string

Jeremiah Kelly

http://www.w3.org/2001/XMLSchema#string

Juan C Troncoso

http://www.w3.org/2001/XMLSchema#string

Kimmo Hatanpaa

http://www.w3.org/2001/XMLSchema#string

Kristin Storie

http://www.w3.org/2001/XMLSchema#string

Roy G Cutler

http://www.w3.org/2001/XMLSchema#string

Ward A Pedersen

http://www.w3.org/2001/XMLSchema#string

P2860

p53-dependent ceramide response to genotoxic stress

Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts

Alzheimer's disease: the cholesterol connection

Molecular analysis of acid ceramidase deficiency in patients with Farber disease

Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin

Functions of lipid rafts in biological membranes

Statin inhibits leukocyte-endothelial interaction and prevents neuronal death induced by ischemia-reperfusion injury in the rat retina.

Apolipoprotein E4: an allele associated with many diseases.

The role of sphingomyelin cycle metabolites in transduction of signals of cell proliferation, differentiation and death.

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

P304

2070-2075

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0305799101

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5787372

http://www.w3.org/2001/XMLSchema#string

P698

14970312

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

357053

http://www.w3.org/2001/XMLSchema#string